Ocumension Therapeutics outlined the current structure of its Board of Directors and the composition of its three standing committees as of 30 June 2026. The Board comprises eight members: one chairperson, two executive directors, three non-executive directors, and three independent non-executive directors.

• Board leadership – Dr. Lian Yong Chen serves as Chairperson and Non-executive Director. – Executive responsibilities are held by Mr. Ye Liu and Dr. Zhaopeng Hu.

• Non-executive representation – Mr. Yanling Cao and Dr. Qin Xie act as Non-executive Directors.

• Independent oversight – Ms. Beibei Zhuang, Mr. Yiran Huang and Mr. Zhenyu Zhang serve as Independent Non-executive Directors, strengthening governance and regulatory compliance.

• Committee assignments 1. Audit Committee: chaired by Ms. Beibei Zhuang with members Dr. Qin Xie, Mr. Yiran Huang and Mr. Zhenyu Zhang. 2. Remuneration Committee: chaired by Mr. Zhenyu Zhang with members Ms. Beibei Zhuang and Mr. Yiran Huang. 3. Nomination Committee: chaired by Ms. Beibei Zhuang with members Dr. Lian Yong Chen, Mr. Yiran Huang and Mr. Zhenyu Zhang.

The disclosure reaffirms Ocumension’s governance framework by clarifying the oversight responsibilities of its directors and the leadership of each committee.